Ovarian Cancer

NEW ORLEANS — Researchers observed increased ovarian aging among women with BRCA1 and BRCA2 mutations, compared with women without the genetic alterations, but decreased ovarian reserve only among those with BRCA1, according to a speaker.

PHILADELPHIA — Current ovarian cancer screening methods are ineffective, but women can reduce their risk for ovarian cancer with opportunistic salpingectomy — removing the fallopian tubes at time of other surgeries, according to a presenter.

Researchers from City of Hope have detailed results of preclinical studies designed to optimize the durability of chimeric antigen receptor T cells for advanced ovarian cancer.

By understanding their bodies, women can identify some of the vaguer symptoms of ovarian cancer at the earliest and most treatable stages of the disease, according to Melissa Simon, MD, MPH.

Because ovarian cancer is one of the more difficult cancers to diagnose, it is important for health care providers and women to understand how symptoms present, how to mitigate risk and how to prevent disease progression.

The addition of tumor-treating fields to chemotherapy did not prolong survival for women with platinum-resistant ovarian cancer, according to the device’s manufacturer.

Identification of inherited genetic mutations that elevate cancer risk and may be susceptible to targeted therapies has transformed oncology care.

A 6-month aerobic exercise intervention significantly improved self-reported chemotherapy-induced peripheral neuropathy among women who underwent chemotherapy for ovarian cancer, according to study results published in JAMA Network Open.

Compared with simple or no surgery, hysterectomy with bilateral salpingo-oophorectomy was associated with reduced risks for ovarian and breast cancer for some women, but increased risks for colorectal cancer and CVD, researchers reported.